![]() JSK Therapeutics JSK Therapeutics is a biotechnology company that engages in developing new anti-cancer therapeutics. | ![]() Virogenics Virogenics is a company that specializes in the research and development of gene therapies and stem cell technology. | ![]() i2o Therapeutics i2o Therapeutics is a company that develops an ionic liquid technology intended to develop the effective oral formulation. | ![]() Accure Therapeutics Accure Therapeutics is a company that develops a drug candidate portfolio in three programs (ACT-01, ACT-02, ACT-03) pursuing innovative targets that focus on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy. | ||
Founding Date | Founding Date N/A | Founding Date 2003 | Founding Date 2014 | Founding Date 2019 | Founding Date 2020 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Salt Lake City, US HQ | Locations San Diego, US HQ | Locations Branford, US HQ | Locations HQ | Locations Barcelona, ES HQ |
Employees | Employees N/A | Employees 4 | Employees 10 | Employees 713% decrease | Employees N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 6m (over 13 years ago) | Latest funding round N/A | Latest funding round $ 4m (about 6 years ago) | Latest funding round $ 8.3m (almost 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 6m | Total funding raised $ 20.8m | Total funding raised $ 4m | Total funding raised $ 8.3m |

Virogenics is a company that specializes in the research and development of gene therapies and stem cell technology.
View company
Azitra is a biotech comapny developing microbiome-based therapeutics to treat skin diseases.
View company
i2o Therapeutics is a company that develops an ionic liquid technology intended to develop the effective oral formulation.
View company
Accure Therapeutics is a company that develops a drug candidate portfolio in three programs (ACT-01, ACT-02, ACT-03) pursuing innovative targets that focus on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy.
View company